MBL International

Founded in 1993 and now a JSR Life Sciences Company, MBL International Corporation (MBLI) provides solutions for researchers in the life sciences, drug discovery and development and clinical diagnostics fields. With a focus on immunology, immuno-oncology, oncology and autoimmune disease and a portfolio including MHC monomers, MHC multimers, antibodies, recombinant proteins, fluorescent proteins and ELISAs, MBLI is committed to improving the probability of success, decreasing timelines, and increasing the efficacy of biologics-based therapies for the benefit of patients.

Europa Biosite’s subsidiaries distribute for MBL International Corporation in Belgium, Denmark, Estonia, Finland, Iceland, Latvia, Lithuania, Luxembourg, Norway, Sweden, Switzerland and the Netherlands.